Literature DB >> 25759934

Gorham disease of the mandible.

Su-Feng Zhao1, Yu-Xin Wang, Xu-Dong Yang, En-Yi Tang.   

Abstract

Gorham disease, or massive osteolysis, is a rare condition of unknown etiology. The disease is characterized by spontaneous progressive osteolysis of 1 or more skeletal bones. The mandible is the most commonly involved bone in the maxillofacial region. This article reports a case of Gorham disease with mandibular involvement in a 46-year-old male patient with a 7-year follow-up. In this case, we performed lower right mandibular osteotomy and reconstruction with a phased titanium plate. Postoperative follow-up showed continued mandibular bone loss that was progressing to the contralateral mandible. Massive osteolysis of the mandible is a rare clinical condition that must be differentiated from mandibularosteomyelitis, benign and malignant tumors, as well as hyperparathyroidism. Improved differential diagnoses and disease follow-up are required to effectively manage massive osteolysis.

Entities:  

Mesh:

Year:  2015        PMID: 25759934     DOI: 10.1097/SCS.0000000000001387

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

Review 1.  Mandibular Gorham-Stout disease: A case report and literature review.

Authors:  Min Liu; Weiwei Liu; Chunyan Qiao; Bing Han
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

Review 2.  Difficult Therapeutic Decisions in Gorham-Stout Disease-Case Report and Review of the Literature.

Authors:  Katarzyna Wojciechowska-Durczynska; Arkadiusz Zygmunt; Marta Mikulak; Marta Ludwisiak; Andrzej Lewinski
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

Review 3.  Gorham-Stout disease of the mandible: case report and review of literature of a rare type of osteolysis.

Authors:  Rohan Jagtap; Swati Gupta; Abdullah Lamfon; Axel Ruprecht; Benjamin Schlott; John Hardeman; Deeba Kashtwari
Journal:  Oral Radiol       Date:  2019-11-18       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.